During Medicine on the Cutting Edge Segment, Physicians and Patients
Discuss Positive Impact of BSGI Test 'Few Women Know About'
NEWPORT NEWS, Va., Oct. 24 /PRNewswire/ -- Last evening, ABC World News
with Charles Gibson aired a Medicine on the Cutting Edge segment regarding
an advanced breast cancer diagnostic test referred to in the story as
Radioactive Imaging, but technically known as Breast-Specific Gamma
Imaging, or BSGI. The story was preceded with Mr. Gibson commenting that
mammograms, the primary form of breast cancer examination, "miss up to 20
percent of cancers."
The segment, reported by John McKensey, featured interviews and
commentaries with notable physicians who have experience using BSGI. The
specialists included breast radiologist Lillian Stern, M.D. of Methodist
Hospital (Jefferson Hospital System) in Philadelphia. During the broadcast
Dr. Stern, using BSGI with the Dilon 6800 Gamma Camera, diagnosed patient
Barbara Hardy as cancer-free after an inconclusive mammogram.
Another patient featured in the story, Ines Fusco, previously had both
a mammogram and ultrasound. Neither test showed any sign of cancer;
however, Ms. Fusco pursued additional testing because she felt a small lump
in her breast. As presented in the segment, Ms. Fusco was then tested with
Breast-Specific Gamma Imaging (BSGI). From the BSGI results, her physician
concluded that she did indeed have a lump, which was cancerous and
subsequently treated. Regarding the BSGI test Ms. Fusco remarked, "I give
it all the credit in the world. It saved my life."
About Breast-Specific Gamma Imaging
Breast-Specific Gamma Imaging (BSGI) with the Dilon 6800 Gamma Camera
is a complementary diagnostic tool to detect breast cancer when
post-mammogram evaluation is indicated. BSGI is able to detect early stage
cancers, identify suspicious and difficult-to-interpret breast
abnormalities, and help differentiate between benign and malignant tumors.
Patients receive a small amount of a radiotracer agent via an injection in
the arm that is absorbed by all cells in their body. Because cancerous
cells have higher metabolic activity, they absorb a greater amount of the
tracer and light up to reveal themselves as "hot spots" to the Dilon 6800.
About Dilon Technologies LLC
Dilon Technologies LLC is bringing innovative new medical products to
the market based on research conducted at leading national research
laboratories. Dilon's cornerstone product is the Dilon 6800 Gamma Camera --
a high- resolution, anatomic-specific gamma camera, which is now being used
to perform Breast-Specific Gamma Imaging (BSGI), a molecular imaging
technique that images the metabolic activity of breast lesions through
radiotracer uptake. Several leading medial centers around the country are
now offering BSGI to their patients, including: Beth Israel Medical Center,
New York; George Washington University Medical Center, Washington, D.C.;
Alexian Brothers Medical Center, Chicago; Breast Health Institute, Orlando;
and West Valley Imaging, Las Vegas.
BSGI with the Dilon 6800 Gamma Camera will be a featured topic of
discussion at ...
The Chicago International Breast Course
Symposium: Breast-Specific Gamma Imaging
Thursday, October 26 from 6:00 to 8:00PM
Grant/ Lincoln Room - River Level 1
The Westin Chicago River North
Speakers: Lillian Stern, M.D., Rachel Brem, M.D. and Jean Weigert, M.D.
BSGI with the Dilon 6800 Gamma Camera will be on display at ...
Radiological Society of North America (RSNA) 92nd Scientific Assembly and
Annual Meeting
November 26 - December 1, 2006
McCormick Place, Chicago, Ill.
North Building, Hall B - Booth #8707
For details about these events contact:
Nancy F. Morter,
Dilon Technologies LLC
C: 757-589-3914
O: 757-269-4910 x02
E: nfmorter@dilon.com
To find out more about BSGI or the Dilon 6800 Gamma Camera please visit
http://www.dilon.com .
SOURCE Dilon Technologies LLC
 back to top
Related links:
http://www.dilon.com
CONTACT:
Nancy F. Morter of Dilon Technologies LLC,
cell, +1-757-589-3914, office, +1-757-269-4910 x02,
nfmorter@dilon.com
|
